Global Diabetic Neuropathy Market

Diabetic Neuropathy Market Size, Share, Growth Analysis, By Disorder(Peripheral Neuropathy, Autonomic Neuropathy), By Distribution channel(Hospitals, Clinics), By Drug Class(Anti-Depressants, Anti-Seizures) - Industry Forecast 2024-2031


Report ID: SQMIG35I2245 | Region: Global | Published Date: February, 2024
Pages: 165 | Tables: 94 | Figures: 76

Diabetic Neuropathy Market Insights

Global Diabetic Neuropathy Market size was valued at USD 3626.38 million in 2019 and is poised to grow from USD 3876.6 million in 2023 to USD 7067.25 million by 2031, growing at a CAGR of 6.9% in the forecast period (2024-2031).

A condition that damages the nerves and is connected to hyperglycemia is diabetic neuropathy. Although diabetic neuropathies' symptoms could not be detected early on, people who have had diabetes for a long period are more likely to experience nerve damage across their bodies. Since diabetic neuropathy cannot be cured, it can be controlled or avoided with the help of a variety of therapeutic approaches. Because of the disease's complexity, regulating agencies are required to authorize additional products and therapy methods that are related to it. Numerous expansion prospects will arise for the businesses operating in this market as a result of the high occurrence of diabetic neuropathy, which affects mainly diabetic individuals.

US Diabetic Neuropathy Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2024-2031

Global Market Size

USD 3626.38 million

Largest Segment

Hospitals

Fastest Growth

Hospitals

Growth Rate

6.9% CAGR

Global Diabetic Neuropathy Market 2022-2028 ($ Mn)
Country Share for North America Region- 2021 (%)
Global Diabetic Neuropathy Market Size by Distribution Channel 2022-2028 (%)
Global Diabetic Neuropathy Market By Distribution Channel, 2021 (%)

To get more reports on the above market click here to Buy The Report

Diabetic Neuropathy Market Segmental Analysis

The Global Diabetic Neuropathy Market segmentation is based on Disorder, Distribution Channel, and Region. Based on disorder the Diabetic Neuropathy Market is segmented into peripheral neuropathy, autonomic neuropathy, proximal neuropathy, and focal neuropathy. Based on distribution channels the Diabetic Neuropathy Market is segmented into hospitals, clinics, retail pharmacies, and online pharmacies. Based on region the global Diabetic Neuropathy market is segmented into North America, Europe, Asia-Pacific, Latin America, and MEA.

Diabetic Neuropathy Market Analysis by Disorder

During the projected timeframe, the world market for diabetic neuropathy is expected to be dominated by the peripheral neuropathy sector. The spread of chronic illnesses like diabetes is a major factor in the sector's expansion. Those with chronic nerve damage and peripheral neuropathy are more likely to develop diabetes. Depending on a variety of factors including age, type of diabetes, glycemic control, and length of diabetes, the occurrence of peripheral diabetic neuropathy in people can vary from 6 to 51 %.

Diabetic Neuropathy Market Analysis by Distribution Channel

The diabetic neuropathy market is majorly driven by the hospital sector, which held the greatest market share in 2021. Hospital visits for routine checkups have dramatically grown as a result of the high number of diabetic patients. Additionally, the expansion of the medical services and rising government backing for programs that evaluate health problems and maintain the health of diabetics are significant factors in the rise of hospitals.

Global Diabetic Neuropathy Market Size by Distribution Channel 2022-2028 ($ Mn), 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Diabetic Neuropathy Market Regional Insights

In 2021, the greatest market for diabetic neuropathy is in North America. In order to counteract the degradation of generic pharmaceuticals, pharma companies continue to give fresh medications in the area. Due to a big incidence of chronic diseases such as diabetes, and an increasing senior generation, diabetic neuropathy treatment has become extremely popular, particularly in the United States.

With economies such as China demonstrating profitable growth, the Asia Pacific area is the fastest-growing market overall. According to studies published, India does have one of the highest proportions of type 2 diabetes in the globe and by 2030, 80 million Indians are expected to have the disease. Due to the region's large population of patients, poorly enforced regulatory environment, rising Research and Development investment, expansion of clinical studies, and federal funding for therapeutic strategies, pharma industries are now expanding there. As a result, the market is expected to experience significant regional growth.

Global Diabetic Neuropathy Market By Geography, 2022-2028, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Diabetic Neuropathy Market Dynamics

Diabetic Neuropathy Market Driver

  • Rise in prevalence of diabetes to cause a rise in the demand for diabetic neuropathy.

Because of the rising prevalence of diabetes, global demand for diabetic neuropathy would grow at a slower rate during the projection period. Furthermore, obesity, coronary heart disease, diabetic neuropathy, and other sugar-related issues are thought to be some of the factors driving the market's expansion. The market's expansion is also influenced by rising urbanization, which promotes sedentary lifestyles such as carbohydrate consumption and low physical activity.

  • Growing research and development activities by key players to fuel the global diabetic neuropathy market.

A surge in diabetes incidence is being caused by an increase in the elderly people and carbohydrate intake. The requirement for treatments for diabetic neuropathy is rising as the world's diabetes population grows. The expansion of the market is also being aided by the rising government expenditures to upgrade health services. The sector for diabetic neuropathy is anticipated to increase in the near future due to the quick advance in science and the rising investments made by the major industry participants.

Diabetic Neuropathy Market Restraint

  • Highly-priced medications and alternative treatments hinder market growth.

The rising expense of medications for treating diabetic neuropathy, the expanding range of alternative medicines, and other considerations are among the barriers to market expansion. One factor limiting the market's potential is the accessibility of other therapies like radiotherapy and physio, which are seen to be more comfortable and may provide consumers with adequate clinical outcomes. The development of this market may also be hampered by the stringent guidelines, product recalls, delays in Food and Drug Administration clearances, and other similar problems.

Request Free Customization of this report to help us to meet your business objectives.

Diabetic Neuropathy Market Competitive Landscape

Due to the rise in R&D projects, Johnson & Johnson and GlaxoSmithKline plc are the major players outperforming the diabetic neuropathy market. Major market companies are being influenced by this to diversify their product offerings globally. As a result, the important companies' varied product portfolios tend to increase the company's value. For instance, The most significant player in the market is thought to be Pfizer Inc. due to its emphasis on creating goods like Motrin and Lyrica that are expected to fuel growth.

Diabetic Neuropathy Market Top Players Company Profiles

  • Johnson & Johnson 
  • Pfizer Inc
  • Eli Lilly and Company
  • Boehringer Ingelheim International GmbH
  • GlaxoSmithKline plc
  • Astellas Pharma Inc.
  • Novartis AG
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • AbbVie Inc.
  • Glenmark Pharmaceuticals Limited
  • Lupin Pharmaceuticals, Inc.
  • Intas Pharmaceuticals Ltd.
  • Alkem Laboratories Ltd.
  • Cipla Limited
  • Mylan N.V.
  • Zydus Cadila Healthcare Limited
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy's Laboratories Ltd.

Diabetic Neuropathy Market Recent Development

  • In January 2022, FDA approved Spinal cord stimulation therapy, according to Medtronic, for the treatment of persistent pain brought on by diabetic peripheral neuropathy.
  • In December 2021, in order to develop "Ask your Doctor," the pharma business P&G Health, with its headquarters in India, collaborated with the English-language local newspaper Hindustan Times. The purpose of this online event is to inform the public about diabetic neuropathy and how to treat it.

Diabetic Neuropathy Key Market Trends

  • During the forecast year, high-tech goods will be developed for better diabetic neuropathy therapy. Companies are concentrating on creating transdermal patches, mouthwash, talc, as well as other products.  Manufacturers have introduced cutting-edge medication delivery systems, like syringe-free injection equipment, to combat problems related to surgical pharmaceuticals. As a result, NFIT has attracted significant interest in the treatment of the disease, which is helping the market expand. As a result, the market is expanding due to the rising demand for new drug delivery methods such as oral, transdermal, parenteral, and inhalation.

Diabetic Neuropathy Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to our analysis, the Peripheral Neuropathy sector dominated the global Diabetic Neuropathy market in 2021 and is anticipated to maintain its dominance throughout the forecast period. The Hospital sector dominated the market share in 2021. In 2021, North America dominated the global diabetic neuropathy market and Asia-Pacific is anticipated to be the fastest-growing region over the forecast period.

Report Metric Details
Market size value in 2023 USD 3626.38 million
Market size value in 2031 USD 7067.25 million
Growth Rate 6.9%
Forecast period 2024-2031
Forecast Unit (Value) USD Million
Segments covered
  • Disorder
    • Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy
  • Distribution channel
    • Hospitals, Clinics, Retail Pharmacy, Online Pharmacy
  • Drug Class
    • Anti-Depressants, Anti-Seizures, Opioid, Non-Steroidal Anti-Inflammatory, and others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Johnson & Johnson 
  • Pfizer Inc
  • Eli Lilly and Company
  • Boehringer Ingelheim International GmbH
  • GlaxoSmithKline plc
  • Astellas Pharma Inc.
  • Novartis AG
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • AbbVie Inc.
  • Glenmark Pharmaceuticals Limited
  • Lupin Pharmaceuticals, Inc.
  • Intas Pharmaceuticals Ltd.
  • Alkem Laboratories Ltd.
  • Cipla Limited
  • Mylan N.V.
  • Zydus Cadila Healthcare Limited
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy's Laboratories Ltd.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

Historical Year 2019

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Diabetic Neuropathy Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Diabetic Neuropathy Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Diabetic Neuropathy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Diabetic Neuropathy Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Diabetic Neuropathy Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Diabetic Neuropathy Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Diabetic Neuropathy Market size was valued at USD 3626.38 million in 2019 and is poised to grow from USD 3876.6 million in 2023 to USD 7067.25 million by 2031, growing at a CAGR of 6.9% in the forecast period (2024-2031).

Due to the rise in R&D projects, Johnson & Johnson and GlaxoSmithKline plc are the major players outperforming the diabetic neuropathy market. Major market companies are being influenced by this to diversify their product offerings globally. As a result, the important companies' varied product portfolios tend to increase the company's value. For instance, The most significant player in the market is thought to be Pfizer Inc. due to its emphasis on creating goods like Motrin and Lyrica that are expected to fuel growth. 'Johnson & Johnson ', 'Pfizer Inc ', 'Eli Lilly and Company', 'Boehringer Ingelheim International GmbH', 'GlaxoSmithKline plc', 'Astellas Pharma Inc.', 'Novartis AG', 'Sanofi S.A.', 'Teva Pharmaceutical Industries Ltd.', 'Merck & Co., Inc.', 'AbbVie Inc.', 'Glenmark Pharmaceuticals Limited', 'Lupin Pharmaceuticals, Inc.', 'Intas Pharmaceuticals Ltd.', 'Alkem Laboratories Ltd.', 'Cipla Limited', 'Mylan N.V.', 'Zydus Cadila Healthcare Limited', 'Sun Pharmaceutical Industries Ltd.', 'Dr. Reddy's Laboratories Ltd.'

Rise in prevalence of diabetes to cause a rise in the demand for diabetic neuropathy.

During the forecast year, high-tech goods will be developed for better diabetic neuropathy therapy. Companies are concentrating on creating transdermal patches, mouthwash, talc, as well as other products.  Manufacturers have introduced cutting-edge medication delivery systems, like syringe-free injection equipment, to combat problems related to surgical pharmaceuticals. As a result, NFIT has attracted significant interest in the treatment of the disease, which is helping the market expand. As a result, the market is expanding due to the rising demand for new drug delivery methods such as oral, transdermal, parenteral, and inhalation.

In 2021, the greatest market for diabetic neuropathy is in North America. In order to counteract the degradation of generic pharmaceuticals, pharma companies continue to give fresh medications in the area. Due to a big incidence of chronic diseases such as diabetes, and an increasing senior generation, diabetic neuropathy treatment has become extremely popular, particularly in the United States.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Diabetic Neuropathy Market

Product ID: SQMIG35I2245

$5,300
BUY NOW GET FREE SAMPLE